BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 8837834)

  • 1. [Cyclosporin in transplantation management--especially after kidney transplantation].
    Quellhorst E
    Internist (Berl); 1996 Jan; 37(1):88-90. PubMed ID: 8837834
    [No Abstract]   [Full Text] [Related]  

  • 2. [Combination of cyclosporin and ketoconazole in immunosuppression schemes in patients with transplanted kidney].
    Treĭvish VS; Shoĭkhet IN; Ankova EV
    Klin Med (Mosk); 1998; 76(1):40-2. PubMed ID: 9532915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion from cyclosporine to tacrolimus in hepatic and renal transplantation.
    Yussim A; Shaharabani E; Mor E; Lustig S; Bar-Nathan N; Shmueli D; Sobolev V; Dorfman B; Or H; Shapira Z
    Transplant Proc; 1996 Dec; 28(6):3178-9. PubMed ID: 8962233
    [No Abstract]   [Full Text] [Related]  

  • 4. Late onset acute rejection of renal allografts, an indicator of suboptimum cyclosporin dosage.
    Sumethkul V; Jirasiritham S; Chiewsilp P
    Transplant Proc; 1996 Jun; 28(3):1461-2. PubMed ID: 8658741
    [No Abstract]   [Full Text] [Related]  

  • 5. Kidney transplant recipients and the incidence of adverse reactions to cyclosporin.
    Tolou-Ghamari Z; Palizban AA
    Saudi Med J; 2004 Oct; 25(10):1499-500. PubMed ID: 15494834
    [No Abstract]   [Full Text] [Related]  

  • 6. Six-year experience with a triple drug protocol in renal transplantation: analysis of risk factors.
    Pallardó LM; Sánchez P; Sánchez J; García J; Orero E; Beneyto I; Cruz JM
    Transplant Proc; 1992 Dec; 24(6):2714-5. PubMed ID: 1465911
    [No Abstract]   [Full Text] [Related]  

  • 7. [Preventing rejection, minimizing toxicity: optimized therapy with cyclosporin].
    MMW Fortschr Med; 2002 Jan; 144(3-4):59. PubMed ID: 11862796
    [No Abstract]   [Full Text] [Related]  

  • 8. Chronic rejection of renal allografts with four immunosuppressive regimens.
    Isoniemi H; Ahonen J; Krogerus L; Eklund B; Höckerstedt K; Salmela K; Häyry P
    Transplant Proc; 1992 Dec; 24(6):2716-7. PubMed ID: 1465912
    [No Abstract]   [Full Text] [Related]  

  • 9. Is acute rejection the key predictor for long-term outcomes after renal transplantation when comparing calcineurin inhibitors?
    Nashan B
    Transplant Rev (Orlando); 2009 Jan; 23(1):47-52. PubMed ID: 19027616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variable cyclosporine exposure: a risk factor for chronic allograft nephropathy and graft loss?
    He X; Johnston A
    Transplant Proc; 2004 Jun; 36(5):1321-6. PubMed ID: 15251323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elective cyclosporine withdrawal in renal transplant recipients maintained on triple therapy.
    Keitel E; Bittar AE; Losekann A; Deboni L; Ceretta F; Goldani JC; Garcia VD
    Transplant Proc; 1992 Dec; 24(6):2606-8. PubMed ID: 1465881
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of acute renal transplant rejection with FK 506 in patients on cyclosporine after failure of standard antirejection therapy.
    Scott-Douglas N; Zimmerman D; Klassen J
    Transplant Proc; 1996 Dec; 28(6):3165. PubMed ID: 8962226
    [No Abstract]   [Full Text] [Related]  

  • 13. Verapamil improves Sandimmune immunosuppression, reducing acute rejection episodes.
    Citterio F; Serino F; Pozzetto U; Fioravanti P; Caizzi P; Castagneto M
    Transplant Proc; 1996 Aug; 28(4):2174-6. PubMed ID: 8769192
    [No Abstract]   [Full Text] [Related]  

  • 14. The long-term outcome of kidney transplantation in patients under cyclosporine--a developing country experience.
    Moosa MR
    Clin Transplant; 2004 Jun; 18(3):267-73. PubMed ID: 15142047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporine pharmacology.
    Lee JI; Canafax DM
    Transplant Proc; 1996 Aug; 28(4):2156-8. PubMed ID: 8769185
    [No Abstract]   [Full Text] [Related]  

  • 16. To keep a stable therapeutic level of cyclosporine during the early posttransplant period is important in graft survival.
    Ahn MS; Ha J; Yun IJ; Kim S; Lee JS; Kim S; Han JS; Ahn C; Choi Y; Cheong HI; Kim ST; Kim SJ
    Transplant Proc; 1996 Jun; 28(3):1316-7. PubMed ID: 8658675
    [No Abstract]   [Full Text] [Related]  

  • 17. Azathioprine can be safely stopped in triple drug induction protocols including cyclosporine and steroids in renal transplantation.
    Pallardó LM; Sánchez J; Sánchez P; García J; Orero E; Beneyto I; Ros F
    Transplant Proc; 1992 Dec; 24(6):2604-5. PubMed ID: 1465880
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term effects of single versus double CsA dosing in kidney transplantation.
    Tarantino A; Montagnino G; Cesana B; Aroldi A; Campise M; Passerini P; Ponticelli C
    Transplant Proc; 2001; 33(7-8):3409-10. PubMed ID: 11750459
    [No Abstract]   [Full Text] [Related]  

  • 19. ISAtx-247 (Isotechnika/Roche).
    Dumont FJ
    Curr Opin Investig Drugs; 2004 May; 5(5):542-50. PubMed ID: 15202729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early steroid withdrawal after renal transplantation.
    Colaneri J
    Nephrol Nurs J; 2006; 33(1):89-90. PubMed ID: 16538935
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.